ascendis pharma glp-1 receptor agonist medications Understanding agonists and their impact on drug discovery GLP-1 Agonists for Weight Loss:

The Weight Regain Question This is one of the hardest conversations in obesity medicine, and it's one that should happen before starting therapy, not after

The Loss of Exclusivity (LOE) of semaglutide in China, Brazil, Canada and India in 2026 will result in the availability of cheaper generics in these countries (and possibly neighbouring countries via parallel import)

To put this into raw numbers, 84 cases of ischemic optic neuropathy were reported in people taking semaglutide over the 7 years

Your care doesnt stop after delivery

In EAT the drug reduced FABP4 and perilipin 1 ( PLIN1 ), but not ADIPOQ expression and on SAT it reduced PPAR coactivator 1-alpha ( PGC1) expression